Management of idiopathic membranous nephropathy

Expert Opin Pharmacother. 2010 Sep;11(13):2163-75. doi: 10.1517/14656566.2010.494599.

Abstract

Importance of the field: Idiopathic membranous nephropathy (IMN) can have a variable natural course. Treatments able to induce remission can improve the long-term prognosis. However, the optimal therapy for IMN remains controversial.

Area covered in this review: We reviewed the historical and current literature from 1979 to 2010 regarding the natural course of IMN and the possible treatments giving special emphasis to randomized controlled trials and to more recent approaches.

What the reader will gain: The reader will gain a comprehensive review of the available treatments of IMN. A personal therapeutic algorithm for nephrotic patients with IMN is also provided.

Take home message: At least five different treatments showed efficacy in many (but not all) patients with IMN.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Glomerulonephritis, Membranous / drug therapy*
  • Glomerulonephritis, Membranous / pathology
  • Glomerulonephritis, Membranous / physiopathology
  • Humans
  • Male
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / pathology
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Treatment Outcome